EMA to review certain injectable medicines to treat allergy
Risks of some methylprednisolone products in patients allergic to cows' milk proteins to be investigated
The European Medicines Agency (EMA) has started a review of certain medicines given by injection to treat severe, rapidly developing (acute) allergic reactions. The medicines involved contain the corticosteroid methylprednisolone as active ingredient. They also include as an additional ingredient lactose (milk sugar), which potentially contains traces of cows' milk proteins that could affect treatment of acute reactions in the small number of highly sensitive patients allergic to these proteins.
More information:
Medicinal products containing lactose of bovine origin for IV/IM use in acute allergic reactions
